[1] BERTOLETTI A，MAINIMK，FERRARI C. The host-pathogen interaction during HBV infection:immunological controversies[J].Antivir Ther，2010，15 （Suppl 3）:15-24.
[2] MIROUX C，VAUSSELIN T，DELHEM N. Regulatory T cells in HBV and HCV liver diseases:implication of regulatory T lymphocytes in the control of immune response[J]. Expert Opin Biol Ther，2010，10（11）:1563-1572.
[3] FISICARO P，VALDATTA C，BONI C，et al． Early kinetics of innate and adaptive immune responses during hepatitis B virus infection[J]. Gut，2009，58（7）:974-982.
[4] INFANTE D，HORTON HF，BYRNE MC，et al． Microbial lipopeptides induce the production of IL-17 in Th cells[J]． J Immunol，2000，165（11）:6107-6115．
[5] PARK H，LI Z，YANG XO，et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17[J]. Nat Immunol，2005，6（11）:1133-1141.
[6] LVANOV II，MCKENZIE BS，ZHOU L，et a1． The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+T helper cells[J]. Cell，2006，126（6）:1121-1133．
[7] MANGAN PR，HARRINGTON LE，O'QUINN DB，et al． Transforming growth factor-beta induces development of the THl7 lineage[J]． Nature，2006，441（7090）:231-234．
[8] STOCKINGER B，VELDHOEN M． Differentiation and function of Thl7 T cells[J]． Curt Opin Immunol，2007，19（3）:281-286．
[9] KORN T，BETTELLI E，OUKKA M，et al. IL-17 and Th17 Cells[J]. Annu Rev Immunol，2009，27:485-517.
[10] SUTTON C，BRERETON C，KEOGH B，et al． A crucial role for interleukin（IL）-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis[J]. J Exp Med，2006，203（7）:1685-1691．
[11] CHEN Z，LAURENCE A，KANNO Y，et al． Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells [J]． Proc Natl Acad Sci USA，2006，103（21）:8137-8142.
[12] BATTEN M，LI J，YI S，et al． Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells[J]． Nat Rev lmmunol，2006，7（9）:929-936．
[13] GAFFEN SL. Structure and signaling in the IL-17 receptor family[J]. Nat Rev Immunol，2009，9（8）:556-567.
[14] STEINMAN L. A brief history of TH17，the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage[J]. Nat Med，2007，13（2）:139-145.
[15] DIAZ JA，BOOTH AJ，LU G，et al. Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection[J]. Am J Transplant，2009，9（8）:1773-1783.
[16] LUBBERTS E，KOENDERS MI，VANDER BW． The role of T cell interleukin-17 in conducting destructive arthritis：lessons from animal models[J]． Arthritis Res，2005，7（1）:29-37．
[17] BETTELLI E，KORN T，OUKKA M，et al. Induction and effector functions of TH17 cells[J]. Nature，2008，453（7198）:1051-1057.
[18] FAUST SM，LU G，MARINI BL，et al. Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection[J]. J Immunol，2009，183（11）:7297-7306.
[19] WILSON MS，MADALA SK，RAMALINGAM TR，et al. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent[J]. J Exp Med，2010，207（3）:535-552.
[20] ZUBER J，BRODIN-SARTORIUS A，LAPIDUS N，et al. FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis[J]. Nephrol Dial Transplant，2009，24（12）:3847-3854.
[21] ZHANG JY，ZHANG Z，LIN F，et al. Interleukin-17-producing CD4+T cells increase with severity of liver damage in patients with chronic hepatitis B[J]. Hepatology，2010，51（1）:81-91.
[22] VELDHOEN M，HOCKING RJ，ATKINS CJ，et al． TGF beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells[J]. Immunity，2006，24（2）:179-189．
[23] KOLLS JK，LINDN A. Interleukin-17 family members and inflammation [J]． Immunity，2004，21（4）:467-476．
[24] LEMMERS A，MORENO C，GUSTOT T，et al． The Interleukin-17 Pathway Is Involved in Human Alcoholic Liver Disease[J]．Hepatology，2009，49（2）:646-657．
[25] RONG G，ZHOU Y，XIONG Y，et al． Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis：the serum cytokine profile and peripheral cell population[J]． Clin Exp Immunol，2009，156（2）:217-225．
[26] SAKAGUCHI S．Regulatory T cells：key controllers of immunologic self-tolerance[J]． Cell，2000，101（5）:455-458．
[27] B1UESTONE JA，ABBAS AK． Natural Versus adaptive regulatory T cells[J]． Nat Rev Immunol，2003，3（3）:253-257．
[28] SAKAGUCHI S. Naturally arising Foxp3-expressing CD25+CD4+regulatory T cells in immunological tolerance to self and non-self[J]. Nat Immunol，2005，6（4）:345-352．
[29] LIU W，PUTNAM AL，XU-YU Z，et al． CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+Treg cells[J]． J Exp Med，2006，203（7）:1701-1711．
[30] LAURENCE A，TATO CM，DAVIDSON TS，et al． Interleukin-2 signaling via STAT5 contains T helper 17 cell generation[J]．Immunity，2007，26（3）:371-381．
[31] XU D，FU J，JIN L，et al． Circulating and 1iver resident CD4+CD25+regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B[J]． J Immunol，2006，177（1）:739-747．
[32] LAN RY，CHENG C，LIAN ZX，et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis[J]. Hepatology，2006，43（4）:729-737.
[33] ORMANDY LA，HILLEMANN T，WEDEMEYER H，et al． Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma[J]. Cancer Res，2005，65（6）:2457-2464．
[34] STOOP JN，VAN DER MOLEN RG，KUIPERS EJ，et al． Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B[J].Virology，2007，361（1）:141-148．
[35] YOU J，HUANG L，ZHANG YF，et al. Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load[J]. World J Gastroenterol，2009，15（27）:3382-3339.
[36] STOOPJN，WOLTMAN AM，BIESTA PJ，et al. Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response[J]． Hepatology，2007，46（3）:699-705．
[37] CHEN MT，BILLAUD JN，SALLBERG M，et al. A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen[J]. Proc Natl Acad Sci USA，2004，101（41）:14913-14918.
[38] ZHANG JY，SONG CH，SHI F，et al. Decreased Ratio of Treg Cells to Th17 Cells Correlates with HBV DNA Suppression in Chronic Hepatitis B Patients Undergoing Entecavir Treatment[J]. Plos One，2010，5:e13869.
[39] ROMAGNANI S.Human Thl7 cells[J]. Arthritis Res Ther，2008，10（2）:206.
[40] HANIDZIAR D，KOULMANDA M. Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance[J]. Curr Opin Organ Transplant，2010，15（4）:411-415.
[41] TSAI HT，TSAI TH，LU TM，et al． Immunopathology of hepatitis B virus infection[J]． Int Rev Immunol，2008，27（6）:427-446．
[42] SPRENGERS D，STOOP JN，BINDA RS，et al. Induction of regulatory T-cells and interleukin-10-producing cells in nonresponders to pegylated interferon-alpha therapy for chronic hepatitis B[J]. Antivir Ther，2007，12（7）:1087-1096.
[43] STOOP JN，VAN DER MOLEN RG，BAAN CC，et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection[J]. Hepatology，2005，41（4）:771-778. |
